Sant Pol de Mar, Spain

Joan Gavalda Santapau


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joan Gavalda Santapau: Innovator in Nanotheranostic Therapy

Introduction

Joan Gavalda Santapau is a pioneering inventor based in Sant Pol de Mar, Spain. She has made significant contributions to the field of nanotechnology, particularly in the development of innovative therapies for antimicrobial resistant infections. Her work focuses on utilizing nanoparticles to enhance treatment efficacy and combat biofilm infections.

Latest Patents

Joan holds a patent for a "System for thermotherapy treatment or prevention of antimicrobial resistant or biofilm infections." This system includes a support designed to receive a nanoparticle assembly (NPA) that can be directed towards a localized area of an organism that is infected or at risk of infection. The NPA consists of multiple nanoparticles, each featuring a metal core that is responsive to thermal energy. An energy unit is incorporated to apply thermal shots to the targeted area, thereby increasing the temperature and enabling a nanotheranostic multimodal antimicrobial therapy. The metal core can be composed of silver, gold, iron, or a combination of silver and gold.

Career Highlights

Throughout her career, Joan has worked with notable institutions such as Fundació Hospital Universitari Vall D'Hebron - Institut De Recerca and Fundació Institut De Bioenginyeria De Catalunya. Her innovative approach and dedication to research have positioned her as a key figure in the field of biomedical engineering.

Collaborations

Joan has collaborated with esteemed colleagues, including Victor Franco Puntes and Eduard Torrents Serra. Their combined expertise has contributed to advancing research in nanotechnology and its applications in medicine.

Conclusion

Joan Gavalda Santapau is a remarkable inventor whose work in nanotheranostic therapy is paving the way for new treatments against antimicrobial resistant infections. Her contributions to the field highlight the importance of innovation in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…